Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Dec 1;4(12):a007997.
doi: 10.1101/cshperspect.a007997.

Wnt signaling in bone development and disease: making stronger bone with Wnts

Affiliations
Review

Wnt signaling in bone development and disease: making stronger bone with Wnts

Jean B Regard et al. Cold Spring Harb Perspect Biol. .

Abstract

The skeleton as an organ is widely distributed throughout the entire vertebrate body. Wnt signaling has emerged to play major roles in almost all aspects of skeletal development and homeostasis. Because abnormal Wnt signaling causes various human skeletal diseases, Wnt signaling has become a focal point of intensive studies in skeletal development and disease. As a result, promising effective therapeutic agents for bone diseases are being developed by targeting the Wnt signaling pathway. Understanding the functional mechanisms of Wnt signaling in skeletal biology and diseases highlights how basic and clinical studies can stimulate each other to push a quick and productive advancement of the entire field. Here we review the current understanding of Wnt signaling in critical aspects of skeletal biology such as bone development, remodeling, mechanotransduction, and fracture healing. We took special efforts to place fundamentally important discoveries in the context of human skeletal diseases.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Mechanisms of skeleton formation. (A) Bones can form by either intramembranous or endochondral ossification. Both processes are initiated by the condensation of mesenchymal cells. During intramembranous ossification, mesenchymal cells differentiate directly into osteoblasts and deposit bone. During endochondral ossification, mesenchymal cells differentiate into chondrocytes and first make a cartilage intermediate. Chondrocytes in the center of the bone initiate a growth plate, stop proliferating, and undergo hypertrophy. Hypertrophic chondrocytes mineralize their matrix and undergo apoptosis, attracting blood vessels and osteoblasts that remodel the intermediate into bone. (B) The first histologic sign of synovial joint formation is the gathering and flattening of cells, forming the interzone. Cavitation occurs within the presumptive joint separating the two cartilaginous structures. Remodeling and maturation proceed to give rise to the mature synovial joint. Wnt signaling plays a significant role in controlling almost all aspects of skeleton formation. Osteoblasts (purple); chondrocytes (blue); osteochondroprogenitor cells (brown).
Figure 2.
Figure 2.
Anatomy of bone. Cortical and trabecular bone represent the two major forms of bone. Osteoblasts (dark purple) are present on the surface and form new bone. Osteocytes (brown) are terminally differentiated osteoblasts that have become embedded in bone and communicate information to one another and to cells on the surface to regulate bone homeostasis. Osteoclasts (blue) are of hematopoietic origin and catabolize bone. A major function of Wnt/β-catenin signaling in osteoblasts is to suppress RANKL and to promote OPG production, thereby inhibiting osteoclast formation.
Figure 3.
Figure 3.
Genetic dissection of skeletal cells using mouse genetics. Schematic diagram of the differentiation of chondrocytes and osteoblasts from a common osteochondral progenitor cell. Overlaid are the corresponding mouse Cre-recombinase lines that allow for the in vivo dissection of signaling pathways. Regulation of cell differentiation by Wnt/β-catenin signaling is indicated (green for activation and red for inhibition). (Figure created from data from Day et al. 2005, Hill et al. 2005, Hu et al. 2005, Rodda and McMahon 2006, Zylstra et al. 2008, and Bonewald 2011.)

References

    1. Agholme F, Li X, Isaksson H, Ke HZ, Aspenberg P 2010. Sclerostin antibody treatment enhances metaphyseal bone healing in rats. J Bone Miner Res 25: 2412–2418 - PubMed
    1. Akhter MP, Wells DJ, Short SJ, Cullen DM, Johnson ML, Haynatzki GR, Babij P, Allen KM, Yaworsky PJ, Bex F, et al. 2004. Bone biomechanical properties in LRP5 mutant mice. Bone 35: 162–169 - PubMed
    1. Akiyama H, Lyons JP, Mori-Akiyama Y, Yang X, Zhang R, Zhang Z, Deng JM, Taketo MM, Nakamura T, Behringer RR, et al. 2004. Interactions between Sox9 and β-catenin control chondrocyte differentiation. Genes Dev 18: 1072–1087 - PMC - PubMed
    1. Albers J, Schulze J, Beil FT, Gebauer M, Baranowsky A, Keller J, Marshall RP, Wintges K, Friedrich FW, Priemel M, et al. 2011. Control of bone formation by the serpentine receptor Frizzled-9. J Cell Biol 192: 1057–1072 - PMC - PubMed
    1. Babij P, Zhao W, Small C, Kharode Y, Yaworsky PJ, Bouxsein ML, Reddy PS, Bodine PV, Robinson JA, Bhat B, et al. 2003. High bone mass in mice expressing a mutant LRP5 gene. J Bone Miner Res 18: 960–974 - PubMed

Publication types